N@N

CVTI, AEZS, MAXY, VVTV, ANGN, CTHR Are Seasonally Ripe To Go Down In the Next Five Weeks

September 16, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of COVENANT TRANSPORT GRP-CL A (NASDAQ:CVTI), AETERNA ZENTARIS INC (NASDAQ:AEZS), MAXYGEN INC (NASDAQ:MAXY), VALUEVISION MEDIA INC-A (NASDAQ:VVTV), ANGEION CORP (NASDAQ:ANGN), CHARLES & COLVARD LTD (NASDAQ:CTHR) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     CVTI       COVENANT TRANSPORT GRP-CL A         -6.52%              100.00% (10 of 10)      Tuesday, October 4th 2011
     AEZS       AETERNA ZENTARIS INC                -19.26%             88.89% (8 of 9)         Friday, October 14th 2011
     MAXY       MAXYGEN INC                         -10.38%             90.00% (9 of 10)        Thursday, October 13th 2011
     VVTV       VALUEVISION MEDIA INC-A             -7.98%              100.00% (10 of 10)      Tuesday, October 4th 2011
     ANGN       ANGEION CORP                        -7.75%              100.00% (8 of 8)        Thursday, September 29th 2011
     CTHR       CHARLES & COLVARD LTD               -7.92%              90.00% (9 of 10)        Monday, September 26th 2011

COVENANT TRANSPORT GRP-CL A (NASDAQ:CVTI) - Covenant Transportation Group, Inc., together with its subsidiaries, offers truckload transportation and brokerage services primarily in the continental United States. The company provides long haul, dedicated, regional solo-driver, and regional temperature-controlled services. It offers its freight brokerage services directly, as well as through freight brokerage agents. The company serves transportation companies, such as freight forwarders, less-than-truckload carriers, and third-party logistics providers, as well as traditional truckload customers, including manufacturers, retailers, and food and beverage shippers. As of December 31, 2009, it operated 3,113 tractors and 8,005 trailers. The company was founded in 1994 and is headquartered in Chattanooga, Tennessee.

AETERNA ZENTARIS INC (NASDAQ:AEZS) - terna Zentaris Inc. operates as a late-stage drug development company specialized in oncology and endocrinology. Its lead oncology compounds include perifosine, an orally active PI3K/Akt pathway inhibitor that is in Phase III registration trial for multiple myeloma; and AEZS-108, a doxorubicin-targeted conjugate in Phase II for the treatment of advanced ovarian and endometrial cancer. The companys lead endocrinology compound, AEZS-130, is an oral ghrelin antagonist in Phase III trial as a diagnostic test for Adult Growth Hormone Deficiency. Its pipeline also includes earlier-stage compounds, such as AEZS-112 that is in a Phase I trial in advanced solid tumors and lymphoma, as well as AEZS-120, an anti-cancer vaccine in pre-clinical development. The company was founded in 1991 and is headquartered in Quebec City, Canada.

MAXYGEN INC (NASDAQ:MAXY) - Maxygen, Inc., a biopharmaceutical company, focuses on developing improved versions of protein drugs. The company utilizes its MolecularBreeding directed evolution technology platform, along with ancillary technologies, and protein modification expertise to pursue the creation of biosuperior proteins. It engages in the discovery, and research and development of multiple protein pharmaceutical programs, including CTLA-4 Ig product candidates that are designed to be CTLA-4 Ig therapeutics for the treatment of an array of autoimmune disorders, including rheumatoid arthritis, and transplant rejection; and MAXY-G34 product candidates for the treatment of chemotherapy-induced neutropenia. The company also focuses on developing biocatalytic process technologies for pharmaceutical, energy, and industrial chemical applications. Maxygen, Inc. was founded in 1996 and is headquartered in Redwood City, California.

VALUEVISION MEDIA INC-A (NASDAQ:VVTV) - ValueVision Media, Inc., a multi-media retailer, engages in marketing, selling, and distributing its products directly to consumers through various digital platforms. It sells mens and womens watches, collectible coins, and other collectible items; gold, gemstone, and fashion jewelry for men and women; and consumer electronics, including desktop and notebook computers and related accessories, as well as home electronics, such as LCD televisions and digital cameras. The company also offers apparel, fashion accessories, and health and beauty products comprising clothing and footwear for women; handbags and other fashion accessories; and cosmetics and personal care items, as well as home and other products, consisting of mattresses, sheet sets, lamps, and home furnishings. Its principal form of multi-media retailing is its television shopping network, ShopNBC, which markets brand name and private label products. The companys other distribution channel includes its Internet retailing Web sites, such as ShopNBC.com and ShopNBC.TV, which provide a range of consumer merchandise, including various products being featured in its television programming. It also provides its products through other digital platforms comprising mobile and social media. ValueVision Media has strategic alliances with GE Capital Equity Investments, Inc. and NBC Universal, Inc. The company was founded in 1990 and is headquartered in Eden Prairie, Minnesota.

ANGEION CORP (NASDAQ:ANGN) - Angeion Corporation, through its subsidiary, Medical Graphics Corporation, develops, manufactures, and markets non-invasive cardio-respiratory diagnostic systems. The companys primary products include pulmonary function and cardiopulmonary exercise testing systems. Its pulmonary function systems are classified into three product categories: Spirometry, Complete Pulmonary Function, and Body Plethysmography. Applications of these products include evaluating the effect of medication; monitoring patients with chronic disease; diagnosing lung diseases, such as chronic obstructive pulmonary disease, asthma, and emphysema; managing treatment; assessing the surgical risk of lung transplant and lung reduction candidates; and evaluating the impact of diseases, such as neuromuscular disease on breathing. The companys cardiopulmonary exercise testing systems measure functional capacity, fitness, or conditioning levels, as well as help physicians diagnose heart and lung diseases. The cardiopulmonary exercise testing systems are used in various applications consisting of distinguishing between cardiovascular and pulmonary disease, screening for early signs of cardiac and pulmonary dysfunction, establishing exercise prescriptions and training programs, and evaluating the efficacy of prescribed therapy. Angeion Corporation also offers cycle ergometer, a specially-designed stationary exercise bicycle that provides healthcare professionals and patients a tool for clinical rehabilitation and athletic training. The company markets its products under the MedGraphics and New Leaf brand names. Angeion Corporation serves hospitals, university-based medical centers, medical clinics, physician offices, health and fitness clubs, weight loss clinics, and personal training studios. It markets its products through direct sales force in the United States; and through a network of independent distributors internationally. The company was founded in 1986 and is based in Saint Paul, Minnesota.

CHARLES & COLVARD LTD (NASDAQ:CTHR) - Charles & Colvard, Ltd. manufactures, markets, and distributes Moissanite jewels for use in fine jewelry in the United States and internationally. It offers near-colorless moissanite jewels cut in various shapes, including round, square brilliant, cushion, radiant, pear, marquise, and oval in sizes ranging from approximately 2 to 12 millimeters, as well as green moissanite jewels. The company primarily sells its loose moissanite jewels to jewel distributors and jewelry manufacturers. It also distributes finished moissanite jewelry to various retailers, including television shopping channels. The company was founded in 1995 and is based in Morrisville, North Carolina.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641